Recombinant adeno-associated virus carrying thymosin &beta;4 suppresses experimental colitis in mice

doi:10.3748/wjg.v23.i2.242

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 23, Issue 2

This Article

(294)

(433)

(0)

(7516)

(26)

Peer-Review Report of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

- Full Article with Cover (PDF)
- Full Article (XML)

Basic Study

World J Gastroenterol. Jan 14, 2017; 23(2): 242-255
Published online Jan 14, 2017. doi: 10.3748/wjg.v23.i2.242

Full Size Figure Download Figure

Figure 6 Adeno-associated virus carrying thymosin β₄ relieved colonic oxidant damage in the mice with colitis. MDA content (A) and SOD activity (B) were determined using biochemical assays. Error bars indicate the SD. AAV: Adeno-associated virus; Tβ₄: Thymosin β₄.

Citation: Zheng XY, Lv YF, Li S, Li Q, Zhang QN, Zhang XT, Hao ZM. Recombinant adeno-associated virus carrying thymosin β₄ suppresses experimental colitis in mice. World J Gastroenterol 2017; 23(2): 242-255
URL: https://www.wjgnet.com/1007-9327/full/v23/i2/242.htm
DOI: https://dx.doi.org/10.3748/wjg.v23.i2.242

Zheng XY, Lv YF, Li S, Li Q, Zhang QN, Zhang XT, Hao ZM. Recombinant adeno-associated virus carrying thymosin β₄ suppresses experimental colitis in mice. World J Gastroenterol 2017; 23(2): 242-255 [PMID: 28127198 DOI: 10.3748/wjg.v23.i2.242]

All content on this site: Copyright © 1993-2026 Baishideng Publishing Group Inc, its licensors, and contributors. All rights are reserved, including those for text and data mining, AI training, and similar technologies. For all open access content, the relevant licensing terms apply.